Intensity Therapeutics Files 8-K: Material Agreement & Equity Sales
Ticker: INTS · Form: 8-K · Filed: Jun 13, 2025 · CIK: 1567264
| Field | Detail |
|---|---|
| Company | Intensity Therapeutics, Inc. (INTS) |
| Form Type | 8-K |
| Filed Date | Jun 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, corporate-action
TL;DR
Intensity Therapeutics signed a new deal and sold some stock. More details in the 8-K.
AI Summary
On June 11, 2025, Intensity Therapeutics, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and other events. This 8-K filing provides updates on the company's corporate activities and financial disclosures.
Why It Matters
This filing indicates significant corporate actions by Intensity Therapeutics, including a new material agreement and equity transactions, which could impact its financial standing and strategic direction.
Risk Assessment
Risk Level: medium — The filing details material agreements and unregistered equity sales, which can introduce financial and operational risks for the company.
Key Players & Entities
- Intensity Therapeutics, Inc. (company) — Registrant
- June 11, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 46-1488089 (identifier) — IRS Employer Identification No.
- 1 Enterprise Drive, Suite 430 Shelton, CT 06484-4779 (address) — Address of Principal Executive Offices
- 203-221-7381 (phone_number) — Registrant's Telephone Number
FAQ
What is the nature of the material definitive agreement entered into by Intensity Therapeutics?
The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on June 11, 2025.
What is the principal executive office address for Intensity Therapeutics?
The principal executive office address for Intensity Therapeutics is 1 Enterprise Drive, Suite 430, Shelton, CT 06484-4779.
What is the company's IRS Employer Identification Number?
The company's IRS Employer Identification Number is 46-1488089.
What are the main items reported in this 8-K filing?
This 8-K filing reports on the entry into a material definitive agreement, unregistered sales of equity securities, other events, and financial statements and exhibits.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 13, 2025 regarding INTENSITY THERAPEUTICS, INC. (INTS).